Global Med Technologies(R), Inc. Completes $580,000 Private Placement
April 28 2004 - 1:30PM
PR Newswire (US)
Global Med Technologies(R), Inc. Completes $580,000 Private
Placement DENVER, April 28 /PRNewswire-FirstCall/ -- Global Med
Technologies(R), Inc. (BULLETIN BOARD: GLOB) ("Global Med" or the
"Company"), is pleased to announce that it has completed a private
placement for the sale of 1,450,000 unregistered common shares of
the Company at $0.40 per share, with gross proceeds of $580,000.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO )
The proceeds of the private placement will be used for working
capital and general operations. After completion of the private
placement and issuance of 1,450,000 common shares, there will be
26,002,296 common shares outstanding. Mick Ruxin, M.D., Chairman
and CEO of Global Med Technologies, Inc., stated, "This private
placement comes at a very exciting time for the Company, as we are
in the process of expanding our domestic and international
operations." Dr. Ruxin continued, "In a previous press release, we
announced Global Med's foray into international markets. I am
pleased to report that our entry into the world markets of blood
bank and hospital transfusion software is progressing more rapidly
than we had expected." About Global Med Technologies, Inc. Global
Med Technologies, Inc. is an e-Health medical information
technology company providing information management software
products and services to the healthcare industry. Its Wyndgate
Technologies division is a leading supplier of information
management systems to U.S. blood centers and transfusion services.
Current clients of Wyndgate's products and services manage more
than 3 million units of blood, or over 22% of the U.S. blood
supply, each year. Together, the SafeTrace Tx(R)* advanced
transfusion management system and the SafeTrace(R) donor management
system provide Vein- to-Vein(R) tracking from donor collection to
patient transfusion. For more information about Global Med's
products and services, call 800- WYNDGATE or visit
http://www.globalmedtech.com/, http://www.peoplemed.com/ and
http://www.wyndgate.com/. This news release may include statements
that constitute forward-looking statements, usually containing the
words "believe," "estimate," "project," "expects" or similar
expressions. These statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this news release. *Patent Pending
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: media, Patti Larson, Senior Director of Marketing
Development, +1-916-404-8492, , or investors, Tom Marcinek,
President and COO, +1-916-404-8413, Web site:
http://www.peoplemed.com/ Web site: http://www.wyndgate.com/ Web
site: http://www.globalmedtech.com/
Copyright